Dayvigo and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Dayvigo (lemborexant), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Xarelto, and have Crohn's disease.

The phase IV clinical study analyzes which people have Joint pain when taking Dayvigo. It is created by eHealthMe based on reports of 1,451 people who have side effects when taking Dayvigo from the FDA, and is updated regularly.

What is Dayvigo?

Dayvigo has active ingredients of lemborexant. It is often used in insomnia. eHealthMe is studying from 1,470 Dayvigo users. Check the latest studies of Dayvigo.

What is Joint pain?

Joint pain is found to be associated with 3,331 drugs and 5,204 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 14, 2026

1,451 people reported to have side effects when taking Dayvigo.
Among them, 23 people (1.59%) have Joint pain.

Among these 23 people:

How long have people been on Dayvigo when they have Joint pain? *

What is the gender of people who have Joint pain when taking Dayvigo? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Joint pain when taking Dayvigo? *

What are other drugs people take besides Dayvigo? *

What are other side effects people have besides Joint pain? *

Fatigue (feeling of tiredness): 15 people, 65.22%
Headache (pain in head): 15 people, 65.22%
Malaise (a feeling of general discomfort or uneasiness): 11 people, 47.83%
Weight Decreased: 10 people, 43.48%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 10 people, 43.48%
Gait Disturbance: 9 people, 39.13%
Depression: 9 people, 39.13%
Muscle Aches (muscle pain): 9 people, 39.13%
Diarrhea: 9 people, 39.13%
General Physical Health Deterioration (weak health status): 8 people, 34.78%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 34.78%
Sleep Disorder: 6 people, 26.09%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 6 people, 26.09%
Procedural Pain: 5 people, 21.74%
Dehydration (dryness resulting from the removal of water): 5 people, 21.74%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 13.04%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 13.04%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 4.35%
Secondary Immunodeficiency (lack of immunity due to some disease): 1 person, 4.35%
High Blood Cholesterol: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Dayvigo and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dayvigo:

Dayvigo (1,470 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

Browse all side effects of Dayvigo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,331 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,204 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lemborexant (the active ingredients of Dayvigo) and Dayvigo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.